Join us in person for this practical, evidence-based update on the management of Type 2 diabetes. The session will cover current treatment guidelines and targets, individualising therapy and selecting appropriate glucose-lowering agents. We'll explore the evolving role of GLP-1 receptor agonists and SGLT2 inhibitors, particularly in cardiovascular and renal disease and discuss practical management considerations in primary care, including treatment intensification and deprescribing where appropriate. Part of the Shire CPD series for GPs.

This event is proudly supported by sponsorship from Canopy Clinical Reasearch

NOTE: This is a licensed venue, please ensure you bring photo ID to sign into the venue.

Presented by: Dr Fatima Iqbal, Endocrinology Advanced Trainee, St George Hospital

Learning Objectives of this session:

• Current treatment guidelines and treatment targets
• Insulin initiation and titration, practical guidance on when to start insulin and how to titrate it safely
• GLP-1 receptor agonists and SGLT2 inhibitors
• Cardiovascular and renal benefits of diabetes therapies
• Deprescribing
• Lifestyle advice – non-pharmacological management

Target audience: GPs

Please note the topics and speakers are subject to change. Please check back for updated information.

*Please note GP Registrars who wish to register for CPD events and do not have a member number will need to contact the CPD Department on 1300 986 991